Tech Company Financing Transactions
Vyome Biosciences Funding Round
On 8/24/2016, Vyome Biosciences secured $14 million in Series C funding from Perceptive Advisors, Aarin Capital Partners and Kalaari Capital.
Transaction Overview
Company Name
Announced On
8/24/2016
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series C
Investors
Proceeds Purpose
Vyome is well positioned with a rich pipeline to become a leader in antimicrobial resistance and treatment of skin infections with this new funding round.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Federal St.
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Vyome Biosciences is an innovation driven company, with a vision to develop novel drugs for antibiotics-resistant acne and other opportunist pathogens through a unique pipeline of antibiotics that retard resistance development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Venkateswarlu Nelabhotla
Chief Medical Officer
Angelo Secci
Browse more venture capital transactions:
Prev: 8/24/2016: SmartEquip venture capital transaction
Next: 8/24/2016: YesVideo venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs